The high costs of patented cancer drugs can have severe financial repercussions for patients. Many individuals face the dilemma of choosing between essential medications and other necessities. Financial toxicity is a term used to describe the economic burden and stress experienced by patients due to the high cost of treatment. This can lead to decreased adherence to medication regimens and poorer health outcomes.
